HOME >> MEDICINE >> NEWS
2005 global tuberculosis targets may be out of reach

An article in this week's issue of THE LANCET cautions that key targets for tuberculosis control-due to be reached by next year-are unlikely to be met unless renewed strategic action and financial support can be secured.

Tuberculosis remains a leading cause of death among adults in less-developed countries; incidence is rising in sub-Saharan Africa and countries in the former Soviet Union. A failure to provide treatment in accordance with the international standard of care can sometimes result in patients being unable to take treatment properly. This can lead to failure to cure the disease and to prevent subsequent relapse.

The tuberculosis control strategy recommended by WHO to tackle this problem is known by the "brand name" of DOTS (DirectObservations of Treatments). The whole DOTS package involves five separate aspects: improved political commitment and funding, diagnosis by a laboratory, regular supplies of essential drugs, strengthened programme supervision, and the use of standard drug treatment with at least the initial treatment being directly observed by a trained treatment supporter.

Mario C. Raviglione from WHO and colleagues discuss how, despite great progress, global targets (70% TB detection of which 85% should be treated) for tuberculosis case detection and cure might not be reached by 2005. The authors highlight the serious case-detection gap between estimated annual incident cases and those reported under the DOTS strategy.

Four key actions are outlined that could speed up progress towards reaching the targets: 1) equipping national tuberculosis programmes to have a stewardship role in engaging all health providers in implementing the DOTS strategy; 2) establishing the feasibility of national certification systems of DOTS coverage; 3) promoting community action to contribute to patient care and to voice demand for the DOTS strategy; and 4) increasing support to sub-Saharan Africa to counter HIV-1-fuelled tubercu
'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
212-633-3810
Lancet
4-Mar-2004


Page: 1 2

Related medicine news :

1. Envisat enables first global check of regional methane emissions
2. New thrust needed to tackle health inequalities globally says UCL scientist
3. A global treatment for iron deficiency
4. 4 million more health workers required to improve global health
5. IU Medical School poised to host global HIV/AIDS conference
6. Tony Blair launches UKs new global AIDS strategy
7. Countries need greater support and less stringent conditions if global fund goals are to be met
8. Chronic diseases need global health attention
9. New global trials help to make FOSRENOL(R) the most extensively studied modern phosphate binder
10. ESC highlights need for screening and global risk management as statins move over the counter in UK
11. Urgent need for investment in human resources to respond to global health crises

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: global tuberculosis targets may out reach

(Date:10/22/2014)... Lintelus, Inc., an event software provider, ... Sales, will be speaking on the subject of “Event ... October 28, at the Holiday Inn in New York ... well as a Tech Demo at 12:45pm, to educate ... more engaging event experience. , The Annual Meetings Technology ...
(Date:10/22/2014)... WALTHAM, MA (PRWEB) October 22, 2014 ... developing new solutions for the treatment of bacterial infections, ... J. Sinskey has joined its board of directors. ... Microbiology and Engineering Systems at The Massachusetts Institute of ... the MIT faculty since 1968. Dr. Sinskey also holds ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. ... fertilization (IVF) are only about half as likely as white ... new research indicates, and the racial disparity persists even when ... percent of white patients became pregnant after IVF, compared to ... 4,000 IVF cycles over two years to tease out the ...
(Date:10/22/2014)... By Tara Haelle ... -- Binge drinking among young adult men may lead to ... binge drinking didn,t cause a similar rise in blood pressure ... study. In fact, when young adult women drank lightly or ... half, the study found. "This finding parallels studies in ...
(Date:10/22/2014)... Measures taken by Firestone officials at the company,s ... the spread of the disease there and could prove ... Co. provides health services to about 80,000 employees, retirees, ... Between Aug. 1 and Sept. 23, there were ... people. That incidence rate of 0.09 percent was much ...
Breaking Medicine News(10 mins):Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 2Health News:Binge Drinking May Boost Blood Pressure in Young Men 3Health News:Binge Drinking May Boost Blood Pressure in Young Men 4Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2
(Date:10/22/2014)... Provectus Biopharmaceuticals, Inc. (NYSEMKT: PVCT) specializes in ... drug for cancer, is designed for injection into solid ... oncology focus is on melanoma, breast cancer and cancers ... of PV-10 as a therapy for metastatic melanoma, and ... and psoriasis. This summer, the Company ...
(Date:10/20/2014)... Oct. 20, 2014  PneumRx, Inc. ( www.pneumrx.com ), ... announced completion of enrollment in their RENEW Study, nearly ... is the FDA-approved IDE pivotal trial for the PneumRx ... It was anticipated that the study, which began ... take until the end of 2014 to enroll 315 ...
(Date:10/20/2014)... , Oct. 20, 2014 Valeritas, Inc., a ... for patients with Type 2 diabetes, announced today that ... Excellence Award. The award was presented October 16 th ... Columbus, Ohio . The ... across a variety of metrics specifically targeted at the ...
Breaking Medicine Technology:Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2PneumRx Completes RENEW Pivotal Trial Enrollment 2PneumRx Completes RENEW Pivotal Trial Enrollment 3Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 2Valeritas Receives 2014 Cardinal Health Supply Chain Excellence Award 3
Cached News: